Logo-apb
Adv Pharm Bull. 2020;10(4): 630-637. doi: 10.34172/apb.2020.076
PMID: 33062603        PMCID: PMC7539305

Research Article

MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression

Ysrafil Ysrafil 1 ORCID, Indwiani Astuti 1 * ORCID, Sumadi Lukman Anwar 2, Ronny Martien 3, Firasti Agung Nugrahening Sumadi 4, Tirta Wardhana 5, Sofia Mubarika Haryana 6

Cited by CrossRef: 6


1- Astuti I, Astuti Y. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):407 [Crossref]
2- Al-Moghrabi N, Al-Showimi M, Al-Yousef N, AlOtai L. MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers. IJMS. 2023;24(10):9021 [Crossref]
3- Davies M, Davey M, Miller N. The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment. Genes. 2022;13(11):2054 [Crossref]
4- Wen A, Luo L, Du C, Luo X. Long non‑coding RNA miR155HG silencing restrains ovarian cancer progression by targeting the microRNA‑155‑5p/tyrosinase‑related protein 1 axis. Exp Ther Med. 2021;22(5) [Crossref]
5- Rastegar-Moghaddam S, Ebrahimzadeh-Bideskan A, Shahba S, Malvandi A, Mohammadipour A. Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target. Cell Mol Neurobiol. 2023;43(2):455 [Crossref]
6- WU M, GUO P, SHI Y, ZHENG D, ZHANG Q, JIN X, WANG Y, LIN Q, FANG R, ZHAO W. Genome-wide analysis of microRNAs induced and regulated by colchicine in mulberry. 2022;46(8):1935 [Crossref]
7- Wardana T, Ysrafil Y, Sumadi F, Martien R, Astuti I, Mubarika S. Suitable reference gene for silencing methods using microRNA encapsulated nanoparticles chitosan for the ovarian cancer cell line. Gene Reports. 2023;33:101855 [Crossref]